title: [Evolution of chronic myeloid leukemia on nilotinib after failure of imatinib].
authors.affiliation: Laboratoire d'hématologie et d'immunologie du Centre hospitalier universitaire Sourô Sanou, 01 BP 676 Bobo-Dioulasso 01 Burkina Faso.
authors.forename: Salifo
authors.initials: S
authors.lastname: Sawadogo
authors.affiliation: Service de médecine interne, Centre hospitalier universitaire Sourô Sanou, 01 BP 676 Bobo-Dioulasso Burkina Faso.
authors.forename: Francis Michel
authors.initials: FM
authors.lastname: Hien
authors.affiliation: Service de médecine interne, Centre hospitalier universitaire Sourô Sanou, 01 BP 676 Bobo-Dioulasso Burkina Faso.
authors.forename: Macaire Sampawendé
authors.initials: MS
authors.lastname: Ouédraogo
authors.affiliation: Service de médecine interne Centre hospitalier universitaire Yalgado Ouédraogo, 03 BP 7022 Ouagadougou 03 Burkina Faso.
authors.forename: Youssouf Joseph
authors.initials: YJ
authors.lastname: Drabo
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D017211:Treatment Failure; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; C498826:nilotinib
keywords: Imatinib; Nilotinib; chronic myeloid leukemia; drug resistance; intolerance